Pfizer Inc. (PFE)

Index:

S&P 100

$ 25.13
   
  • Change Today:
    $0.19
  • 52 Week High: $31.39
  • 52 Week Low: $24.78
  • Currency: US Dollars
  • Shares Issued: 5,646m
  • Volume: 45,048,363
  • Market Cap: $141,884m
  • RiskGrade: 102
  • Beta: 0.24

Pfizer Overview

In 1849, Charles Pfizer & Company opened as a fine-chemicals business. Now, as a research-based, global pharmaceutical company, Pfizer is the world's largest company devoted to healthcare, with products available in more than 150 countries. In June 2000, Pfizer completed the acquisition of Warner-Lambert, creating the world's most valuable and fastest-growing pharmaceutical company, and, in April 2003, merged with Pharmacia Corporation, enlarging Pfizer's portfolio of consumer healthcare brands and expanding its animal health business.

1 Day Chart (21-11-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Pfizer Financials

Latest F'cast
Div Yield 6.6%
Div Cover 0.2
Op Mrgn 1.8%
ROCE 3.7%
Latest F'cast
P/E 66.1
PEG n/a
Pr/Revenue 2.4
Pr/Book 1.6
Latest F'cast
Revenue -41.7%
PBT -97.0%
EPS -93.2%
DPS 2.5%

Pfizer Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 41,172.00 11,485.00 191.00¢ 20.5 n/a 0% 146.00¢ 3.7%
31-Dec-20 41,651.00 7,036.00 119.00¢ 30.9 n/a -38% 153.00¢ 4.2%
31-Dec-21 81,288.00 24,311.00 400.00¢ 14.8 0.1 +236% 157.00¢ 2.7%
31-Dec-22 100,330.00 34,729.00 559.00¢ 9.2 0.2 +40% 161.00¢ 3.1%
31-Dec-23 58,496.00 1,058.00 38.00¢ 75.8 n/a -93% 165.00¢ 5.7%

Pfizer Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 62,972.75 20,343.94 292.86¢ 8.6 0.0 +671% 168.32¢ 0.0%
31-Dec-25 63,214.77 20,855.56 293.41¢ 8.6 45.4 0% 171.68¢ 0.0%
31-Dec-26 63,774.34 21,822.39 308.39¢ 8.1 1.6 +5% 171.48¢ 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Pfizer ShareCast News

Company veteran named chief scientific officer a... 20-Nov-2024 ShareCast
Pfizer lifts full-year guidance on bumper Q3 sales 29-Oct-2024 ShareCast
Pfizer lifts outlook on strong Q2 sales 30-Jul-2024 ShareCast

Pfizer Top Newspaper Links

Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Pfizer Market Data

Currency US Dollars
Share Price $ 25.13
Change Today $ 0.19
% Change 0.76 %
52 Week High $31.39
52 Week Low $24.78
Volume 45,048,363
Shares Issued 5,646m
Market Cap $141,884m
Beta 0.24
RiskGrade 102

What The Brokers Say

Strong Buy 3
Buy 6
Neutral 14
Sell 0
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 21-Nov-2024

Time Volume / Share Price
15:59 100 @ $25.13
15:59 100 @ $25.13
15:59 100 @ $25.13
15:59 200 @ $25.13
15:59 200 @ $25.13

Top of Page